Gene Therapy Trial Designs For Bleeding Disorders Could See Patient Input At FDA Meeting

During its patient-focused drug development meeting on hemophilia, von Willebrand Disease and other bleeding disorders, the agency will ask patients about how they decide whether to join a clinical trial.